Eligibility criteria for programmed death receptor 1 inhibitors vs. real‐world advice: a retrospective analysis of 69 patients with advanced cutaneous squamous cell carcinoma of the head and neck. (1st February 2022) - Leus, A.J.G.; Horváth, B.; Terra, J.B.; Diercks, G.F.H.; Plaat, B.E.C.; Oosting, S.F.; Rácz, E.